Abstract
Purpose: Accurate assessment of the pressure gradient (ΔP) across aortic coarctation (CoA) is critical for determining disease severity and the need for intervention. Current non-invasive methods are unreliable, while invasive catheterization remains the clinical gold standard. This study evaluates a novel MRI acquisition strategy, 4D-FlowP, that simultaneously encodes blood velocity and acceleration to enable reliable non-invasive pressure gradient mapping in CoA. Methods: Patient-specific compliant aortic phantoms were created from clinical MRI data of two patients with CoA. Additional geometries were synthetically generated by increasing stenosis severity. Phantoms were studied in an MRI compatible flow loop under physiologically realistic flow and pressure conditions. Pressure gradients were estimated using conventional 4D-Flow MRI, 4D-FlowP, and fluid-structure interaction (FSI) simulations. Results were compared against ground-truth catheter-based measurements across multiple flow rates and stenosis severities. Results: Conventional 4D-Flow consistently underestimated ΔP (slope = 0.63, R2=0.75) relative to catheter measurements. In contrast, 4D-FlowP demonstrated substantially improved agreement (slope = 0.95, R2=0.75). FSI simulations showed the highest overall agreement with catheter-derived ΔP (slope = 1.14, R2=0.82). Scan times for 4D-FlowP were comparable to 4D-Flow (26 vs. 24 minutes). Conclusion: 4D-FlowP enables a more accurate MRI-based pressure gradient mapping in CoA than conventional 4D-Flow, when compared to ground truth catheter measurements. These findings support further in vivo evaluation of 4D-FlowP as a non-invasive alternative for functional assessment of CoA severity
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The retrospective use of patient data for this work was approved by the IRB at Stanford University.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the work are available online at https://doi.org/10.25740/ms528wr9373 and https://vascularmodel.org/
Funder Information Declared
